151 related articles for article (PubMed ID: 10625646)
1. Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine.
Gerbaud V; Pignol D; Loret E; Bertrand JA; Berland Y; Fontecilla-Camps JC; Canselier JP; Gabas N; Verdier JM
J Biol Chem; 2000 Jan; 275(2):1057-64. PubMed ID: 10625646
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic lithostathine as a calcite habit modifier.
Geider S; Baronnet A; Cerini C; Nitsche S; Astier JP; Michel R; Boistelle R; Berland Y; Dagorn JC; Verdier JM
J Biol Chem; 1996 Oct; 271(42):26302-6. PubMed ID: 8824282
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor?
Bimmler D; Graf R; Scheele GA; Frick TW
J Biol Chem; 1997 Jan; 272(5):3073-82. PubMed ID: 9006958
[TBL] [Abstract][Full Text] [Related]
4. [Pancreatic lithostathine inhibitor of calcium carbonate precipitation: structure-function relationship].
Bernard JP; Takacs T; de Reggi M; Sarles H; Dagorn JC
Nephrologie; 1993; 14(6):257-9. PubMed ID: 8145882
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nucleation and crystal growth of calcium carbonate by human lithostathine.
Bernard JP; Adrich Z; Montalto G; De Caro A; De Reggi M; Sarles H; Dagorn JC
Gastroenterology; 1992 Oct; 103(4):1277-84. PubMed ID: 1397886
[TBL] [Abstract][Full Text] [Related]
6. Lithostathine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals.
De Reggi M; Gharib B; Patard L; Stoven V
J Biol Chem; 1998 Feb; 273(9):4967-71. PubMed ID: 9478942
[TBL] [Abstract][Full Text] [Related]
7. An insight into the role of human pancreatic lithostathine.
Patard L; Lallemand JY; Stoven V
JOP; 2003 Mar; 4(2):92-103. PubMed ID: 12629266
[TBL] [Abstract][Full Text] [Related]
8. Lithostathine, an inhibitor of CaCO3 crystal growth in pancreatic juice, induces bacterial aggregation.
Iovanna J; Frigerio JM; Dusetti N; Ramare F; Raibaud P; Dagorn JC
Pancreas; 1993 Sep; 8(5):597-601. PubMed ID: 8302796
[TBL] [Abstract][Full Text] [Related]
9. Calcium carbonate crystals promote calcium oxalate crystallization by heterogeneous or epitaxial nucleation: possible involvement in the control of urinary lithogenesis.
Geider S; Dussol B; Nitsche S; Veesler S; Berthézène P; Dupuy P; Astier JP; Boistelle R; Berland Y; Dagorn JC; Verdier JM
Calcif Tissue Int; 1996 Jul; 59(1):33-7. PubMed ID: 8661982
[TBL] [Abstract][Full Text] [Related]
10. Crystallization and preliminary crystallographic study of human lithostathine.
Pignol D; Bertrand JA; Bernard JP; Verdier JM; Dagorn JC; Fontecilla-Camps JC
Proteins; 1995 Dec; 23(4):604-6. PubMed ID: 8749859
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation.
Bertrand JA; Pignol D; Bernard JP; Verdier JM; Dagorn JC; Fontecilla-Camps JC
EMBO J; 1996 Jun; 15(11):2678-84. PubMed ID: 8654365
[TBL] [Abstract][Full Text] [Related]
12. Evidence that human kidney produces a protein similar to lithostathine, the pancreatic inhibitor of CaCO3 crystal growth.
Verdier JM; Dussol B; Casanova P; Daudon M; Dupuy P; Berthezene P; Boistelle R; Berland Y; Dagorn JC
Eur J Clin Invest; 1992 Jul; 22(7):469-74. PubMed ID: 1516594
[TBL] [Abstract][Full Text] [Related]
13. Human lithostathine S2-5: a relevant inhibitor of pancreatic stone formation?
Bimmler D; Graf R; Frick T
Pancreas; 1999 May; 18(4):417-8. PubMed ID: 10231850
[No Abstract] [Full Text] [Related]
14. Biophysical characterization of lithostathine. Evidences for a polymeric structure at physiological pH and a proteolysis mechanism leading to the formation of fibrils.
Cerini C; Peyrot V; Garnier C; Duplan L; Veesler S; Le Caer JP; Bernard JP; Bouteille H; Michel R; Vazi A; Dupuy P; Michel B; Berland Y; Verdier JM
J Biol Chem; 1999 Aug; 274(32):22266-74. PubMed ID: 10428794
[TBL] [Abstract][Full Text] [Related]
15. [Renal lithostathine: a new protein inhibitor of lithogenesis].
Verdier JM; Dussol B; Casanova P; Daudon M; Dupuy P; Berthezène P; Boistelle R; Berland Y; Dagorn JC
Nephrologie; 1993; 14(6):261-4. PubMed ID: 8145883
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of calcium carbonate crystal growth by the cysteine-rich Mdm2 peptide.
Dalas E; Chalias A; Gatos D; Barlos K
J Colloid Interface Sci; 2006 Aug; 300(2):536-42. PubMed ID: 16678843
[TBL] [Abstract][Full Text] [Related]
17. Protein inhibitors of calcium salt crystal growth in saliva, bile and pancreatic juice.
Verdier JM; Dussol B; Berland Y; Dagorn JC
Scanning Microsc; 1993 Sep; 7(3):1017-30. PubMed ID: 8146603
[TBL] [Abstract][Full Text] [Related]
18. A family of 16-kDa pancreatic secretory stress proteins form highly organized fibrillar structures upon tryptic activation.
Graf R; Schiesser M; Scheele GA; Marquardt K; Frick TW; Ammann RW; Bimmler D
J Biol Chem; 2001 Jun; 276(24):21028-38. PubMed ID: 11278730
[TBL] [Abstract][Full Text] [Related]
19. What function for human lithostathine?: structural investigations by three-dimensional structure modeling and high-resolution NMR spectroscopy.
Patard L; Stoven V; Gharib B; Bontems F; Lallemand JY; De Reggi M
Protein Eng; 1996 Nov; 9(11):949-57. PubMed ID: 8961348
[TBL] [Abstract][Full Text] [Related]
20. Design of a synthetic foldamer that modifies the growth of calcite crystals.
Estroff LA; Incarvito CD; Hamilton AD
J Am Chem Soc; 2004 Jan; 126(1):2-3. PubMed ID: 14709030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
